News

Capricor Therapeutics's dip caused by the CRL is a buying opportunity considering the readout of HOPE-3 within 2-3 months.
In this study, we present a first-of-a-kind biological-hardware-software tool to evaluate the physiological condition of in vitro myotubes in response to electrical stimulation. We demonstrate that ...
Their symptoms include skeletal muscle weakness, arrhythmias, heart failure, and accumulation of desmin in cardiac and skeletal muscle cells. The desmin accumulation can be caused by desmin mutations ...
Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...